Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Salbutamol Sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 28 USDMF, 13 CEP/COS, 1 JDMF, 11 EU WC, 2 KDMF, 23 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

190 Drugs in Development

190 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

428 FDF Dossiers, 135 FDA Orange Book, 149 Europe, 20 Canada, 16 Australia, 43 South Africa, 65 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 1 ACG Worldwide, 11 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 CD Formulation, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 3 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 27 Thickeners and Stabilizers, 26 Direct Compression, 25 Granulation, 24 Controlled & Modified Release, 19 Taste Masking, 18 Film Formers & Plasticizers, 17 Disintegrants & Superdisintegrants, 16 Topical, 16 Lubricants & Glidants, 13 Parenteral, 11 Co-Processed Excipients, 10 Solubilizers, 9 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 96 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 83 Regulatory FDF Prices, 21 Annual Reports

MARKET PLACE

33 APIs, 14 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 31 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Cambrex Corporation	U.S.A	Cambrex Profarmaco Milano S. r. l.	219MF10285	Albuterol sulfate	2007-09-10	2025-03-26	Via Curiel 34, 20067 Paulo, Milano, ITALY

Salbutamol Sulfate

Salbutamol Sulfate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers

28 USDMF

13 CEP/COS

1 JDMF

11 EU WC

2 KDMF

23 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

190 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

428 FDF Dossiers

135 FDA Orange Book

149 Europe

20 Canada

16 Australia

43 South Africa

65 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

6 SPI Pharma

10 DKSH

1 Pharm-RX Chemical

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

6 Kirsch Pharma

1 ACG Worldwide

11 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 CD Formulation

11 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

3 Finar

6 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

23 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

26 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders

45 Coating Systems & Additives

27 Thickeners and Stabilizers

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons